EGR1 regulates cellular metabolism and survival in endocrine resistant breast cancer

About 70% of all breast cancers are estrogen receptor alpha positive (ER+; ESR1). Many are treated with antiestrogens. Unfortunately, de novo and acquired resistance to antiestrogens is common but the underlying mechanisms remain unclear. Since growth of cancer cells is dependent on adequate energy...

Descripción completa

Detalles Bibliográficos
Autores principales: Shajahan-Haq, Ayesha N., Boca, Simina M., Jin, Lu, Bhuvaneshwar, Krithika, Gusev, Yuriy, Cheema, Amrita K., Demas, Diane D., Raghavan, Kristopher S., Michalek, Ryan, Madhavan, Subha, Clarke, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722529/
https://www.ncbi.nlm.nih.gov/pubmed/29228577
http://dx.doi.org/10.18632/oncotarget.18292

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722529/
https://www.ncbi.nlm.nih.gov/pubmed/29228577
http://dx.doi.org/10.18632/oncotarget.18292

Ejemplares similares